Subscribe To
Catalyst pharmaceuticals to report third quarter 2023 financial results on november 8, 2023
The Company to Host a Conference Call and Webcast on November 9, 2023, at 8:30 AM ET CORAL GABLES, Fla., Oct. 23, 2023 (GLOBE NEWSWIRE) — Catalyst P...
October 23, 2023, 12:03 pm
What makes crinetics pharmaceuticals, inc. (crnx) a good fit for 'trend investing'
Crinetics Pharmaceuticals, Inc. (CRNX) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a ...
October 23, 2023, 10:34 am
Why is xortx therapeutics (xrtx) stock down 27% today?
Xortx Therapeutics (NASDAQ: XRTX ) stock is sliding lower on Monday as the pharmaceutical company's sh...
October 23, 2023, 9:10 am
Catalyst pharmaceuticals to report third quarter 2023 financial results on november 8, 2023
The Company to Host a Conference Call and Webcast on November 9, 2023, at 8:30 AM ET The Company to Host a Conference Call and Webcast on November 9, ...
October 23, 2023, 8:03 am
Encouraging preliminary data from a phase 2 trial evaluating io102-io103 in combination with pembrolizumab for first-line treatment of patients with non-small cell lung cancer and squamous cell carcin
NEW YORK, Oct. 23, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical ...
October 23, 2023, 5:00 am
Encouraging preliminary data from a phase 2 trial evaluating io102-io103 in combination with pembrolizumab for first-line treatment of patients with non-small cell lung cancer and squamous cell carcin
NEW YORK, Oct. 23, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical ...
October 23, 2023, 5:00 am
Encouraging preliminary data from a phase 2 trial evaluating io102-io103 in combination with pembrolizumab for first-line treatment of patients with non-small cell lung cancer and squamous cell carcin
NEW YORK, Oct. 23, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical ...
October 23, 2023, 5:00 am
Encouraging preliminary data from a phase 2 trial evaluating io102-io103 in combination with pembrolizumab for first-line treatment of patients with non-small cell lung cancer and squamous cell carcin
NEW YORK, Oct. 23, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical ...
October 23, 2023, 5:00 am
Encouraging preliminary data from a phase 2 trial evaluating io102-io103 in combination with pembrolizumab for first-line treatment of patients with non-small cell lung cancer and squamous cell carcin
NEW YORK, Oct. 23, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical ...
October 23, 2023, 5:00 am
Merck discontinues some cancer drug development with china's sichuan kelun
Chinese drugmaker Sichuan Kelun pharmaceutical Co said on Monday that Merck & Co Inc was abandoning the...
October 23, 2023, 3:47 am
Mallinckrodt to present data on terlivaz® (terlipressin) for injection in adult patients with hepatorenal syndrome (hrs) at the american college of gastroenterology (acg) annual scientific meeting
– Findings from two clinical studies and one health economic database analysis provide insight into HRS treatment outcomes with TERLIVAZ,1 patients'...
October 22, 2023, 3:05 pm
Eli lilly, novo nordisk to test weight loss drugs for children
pharmaceutical manufacturers Eli Lilly (LLY) and Novo Nordisk (NVO) are reportedly planning to test the...
October 22, 2023, 11:00 am
Bristol-myers squibb acquisition of mirati makes sense
Bristol Myers Squibb is a large pharmaceutical company with a strong dividend yield and impressive asse...
October 22, 2023, 8:53 am
Libtayo® (cemiplimab) neoadjuvant treatment demonstrates encouraging event-free survival in patients with resectable cutaneous squamous cell carcinoma (cscc)
89% estimated event-free survival at one year among patients with stage II to IV resectable CSCC who received Libtayo prior to surgery in a Phase 2 tr...
October 21, 2023, 12:48 pm
Bristol-myers squibb: time to get greedy
Buying Bristol-Myers now could be a practical application of Buffett's advice to be greedy when others are fearful. As it stands right now, the ...
October 21, 2023, 10:24 am
Dmk pharmaceuticals announces inducement option grant under nasdaq listing rule 5635(c)(4)
SAN DIEGO, Oct. 20, 2023 (GLOBE NEWSWIRE) — DMK Pharmaceuticals Corporation (NASDAQ: DMK), a commercial-stage bio...
October 20, 2023, 8:15 pm
Ligand pharmaceuticals (lgnd) sees a more significant dip than broader market: some facts to know
In the closing of the recent trading day, Ligand Pharmaceuticals (LGND) stood at $52.09, denoting a -1.31% change from the preceding trading day....
October 20, 2023, 7:33 pm
Ani pharmaceuticals (anip) increases despite market slip: here's what you need to know
ANI Pharmaceuticals (ANIP) closed at $57.44 in the latest trading session, marking a +0.23% move from the prior day....
October 20, 2023, 7:33 pm
Trending tickers: at&t, merck-daiichi sankyo, klaviyo: trending tickers october 29, 2023
Scotiabank analysts upgrade AT&T (T) stock from "Sector Perform" to "Sector Outperform." Merck (MRK) strikes a deal worth up to $22 billion with Japan...
October 20, 2023, 5:44 pm
Pharma firms testing weight loss drugs for kids amid ozempic craze
Get ready for Ozem-kids! The pharmaceutical companies behind Ozempic, Mounjaro and Wegovy — which hav...
October 20, 2023, 5:12 pm